These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15529601)

  • 1. Inflammatory response after dexamethasone eluting coronary stent implantation.
    Mut-Vitcu B; Drăgulescu SI; Drăgulescu A; El Kahlout A; Coroban A; Maximov D; Slovenski M
    Rom J Intern Med; 2004; 42(1):119-27. PubMed ID: 15529601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention.
    Patti G; Pasceri V; Carminati P; D'Ambrosio A; Carcagnì A; Di Sciascio G
    Am J Cardiol; 2005 Feb; 95(4):502-5. PubMed ID: 15695139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.
    Liu X; De Scheerder I; Desmet W
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):653-60. PubMed ID: 15350167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myonecrosis and inflammatory response following percutaneous coronary angioplasty. A protective role for betablockers?].
    Radulescu B; Morel O; Faure A; Jesel L; Roul G; Chauvin M; Ohlmann P; Bareiss P
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):27-33. PubMed ID: 18656848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Koskinas K; Gemitzis K; Hatzimiltiadis S; Efthimiadis G; Paraskevaidis S; Hatzitolios A; Savopoulos C; Parharidis G
    Med Sci Monit; 2009 Apr; 15(4):CR177-84. PubMed ID: 19333202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
    Chyrchel M; Dudek D; Bartuś S; Legutko J; Heba G; Dubiel JS
    Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study.
    Han SH; Ahn TH; Kang WC; Oh KJ; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Am Heart J; 2006 Nov; 152(5):887.e1-7. PubMed ID: 17070150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting.
    Guler N; Batyraliev T; Dulger H; Ozkara C; Tuncer M; Aslan S; Okut H; Agirbasli M
    Int J Cardiol; 2006 May; 109(3):339-43. PubMed ID: 16040142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
    Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
    Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.